StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$13.24−0.56 (-4.06%)

Close on Nov 17, 2026Market cap $2.00BP/E –Yield –

Biohaven EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Biohaven's EPS for the twelve months ending Sep 30, 2026 was -$3.86. For fiscal 2025 it was -$6.86. The highest annual figure on record is -$3.01 in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.86–
FY2024Dec 31, 2024-$9.28–
FY2023Dec 31, 2023-$5.73–
FY2022Dec 31, 2022-$12.75–
FY2021Dec 31, 2021-$5.43–
FY2020Dec 31, 2020-$3.01–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.86–
Q2 FY2026Jun 30, 2026-$0.91–
Q1 FY2026Mar 31, 2026-$0.88–
Q4 FY2025Dec 31, 2025-$1.21–
Q3 FY2025Sep 30, 2025-$1.64–
Q2 FY2025Jun 30, 2025-$1.94–
Q1 FY2025Mar 31, 2025-$2.17–
Q4 FY2024Dec 31, 2024-$1.85–
Q3 FY2024Sep 30, 2024-$1.70–
Q2 FY2024Jun 30, 2024-$3.64–
Q1 FY2024Mar 31, 2024-$2.20–
Q4 FY2023Dec 31, 2023-$1.81–
Q3 FY2023Sep 30, 2023-$1.50–
Q2 FY2023Jun 30, 2023-$1.32–
Q1 FY2023Mar 31, 2023-$1.03–
Q4 FY2022Dec 31, 2022-$3.31–
Q3 FY2022Sep 30, 2022-$1.75–
Q2 FY2022Jun 30, 2022-$5.16–
Q1 FY2022Mar 31, 2022-$2.46–
Q4 FY2021Dec 31, 2021-$1.32–
Q3 FY2021Sep 30, 2021-$1.38–

More Biohaven figures

See a number that looks wrong?